Share on LinkedInShare on LinkedIn

ARTICLE · 08 MAY 2024

DEA Moves To Reclassify Marijuana As A Schedule III Drug

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry.

United StatesCannabis & Hemp
David M. DiGiacomo
David M. DiGiacomo

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry. Additionally rescheduling would lift the burden of 280E from legal cannabis operators. Regulatory change will involve notice and comment rulemaking - a potentially lengthy process - we will continue to follow as this develops.

US drug control agency will move to reclassify marijuana in a historic shift, AP sources say

apnews.com/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from